
Amcor
Amcor, a packaging firm based in Switzerland, has initiated customer trials of its new AmSky recyclable polyethylene-based thermoformed blister packaging. The new packaging is designed to meet the requirements of highly specialized and regulated pharmaceutical packaging. According to a news release from Amcor, the new design “creates a more sustainable alternative for the most in-demand health care packaging type.”
The AmSky blister system eliminates polyvinyl chloride (PVC) from the packaging by using a monomaterial polyethylene (PE) thermoform blister and lidding film. According to Amcor, PVC can make packaging recycling more difficult or contaminate other materials if consumers attempt to recycle it. By removing PVC, Amcor has developed a new, recyclable solution.
Amcor reports that it is working with pharmaceutical companies to bring AmSky to market globally. The company expects AmSky to be available in the health care market by the second half of 2022.
“Amcor is deploying our unique innovation capabilities to solve the biggest and most significant issues in packaging today,” says Peter Konieczny, Amcor’s chief commercial officer. “With AmSky Amcor has signaled our commitment to breakthrough innovation in the health care space—this is why we remain the packaging partner of choice for our healthcare customers, generating close to $2 billion in annual sales in this market. This new blister packaging solution will significantly enhance the ability of health care and pharmaceutical brands to put sustainability at the heart of their businesses.”
Latest from Recycling Today
- Steel Dynamics announces operational senior leadership transitions
- BCMRC 2025 session preview: Evolution of battery chemistries
- Emirates Aluminum picks Oklahoma for US facility site
- WM names company president
- Can Manufacturers Institute, Recycling is like Magic release aluminum can recycling contest results
- WasteExpo 2025: EPR implementation requires collaboration, harmonization
- GP to shutter containerboard mill in Georgia
- Vallourec reports slimmer profits in Q1